Search

everythinglearnresearchcommunity

for

Search:↓

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Men who start puberty later may have lower sperm quality and different hormone levels in adulthood.

Darker skin in 10-year-old girls may be an early sign of puberty.

Early sexual development in children, especially girls, can be treated with hormone therapy to improve adult height and requires support for the child and family.

Early puberty is more common in girls and African-American children, possibly due to nutrition, obesity, stress, and environmental factors, and is treated with hormone therapy.

Precocious puberty is starting earlier due to factors like obesity and chemicals, with treatment focusing on preserving height and addressing social issues.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Primary amenorrhea and delayed puberty in females can be diagnosed and managed effectively.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Selecting Angus cattle for earlier puberty lowers prolactin levels but doesn't affect hair growth.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.